Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting

Thrombosis Journal

Volumn 5, Issue , 2007, Pages

  Le Hello, Claire ^a   Morello, Rémy ^b   Lequerrec, Agnès ^a   Duarte, Christine ^a   Riddell, John ^a   Hamon, Martial ^a,c  

^a Academic Hospital of Caen   (France)

^b Universitary Hospital Caen   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOPROTEIN IIIA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DNA POLYMORPHISM; FEMALE; FRANCE; GENOTYPE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTOR; THROMBOSIS;

EID: 38349022512     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-5-19     Document Type: Article

References (30)

1. Shiffman D Rowland CM Sninsky JJ Devlin JJ Polymorphisms associated with coronary heart disease: Better by the score Curr Opin Mol Ther 2006, 8:493-499. 17243484
2. Nurden AT Nurden P A review of the role of platelet membrane glycoprotein in the platelet-vessel wall interaction Bailliere's Clin Haematol 1993, 6:653-690. 10.1016/S0950-3536(05)80193-3
3. Lefkovits J Plow EF Topol EJ Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine N Engl J Med 1995, 332:1553-1559. 10.1056/ NEJM199506083322306 7739710
4. Newman PJ Derbes RS Aster RH The human platelet alloantigens, PlA1 and PlA2 are associated with a leucine 33 to proline aminoacid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing J Clin Invest 1989, 83:1778-1781. 303891 2565345
5. Feng D Lindpaintner K Larson MG Rao VS O'Donnell CJ Lipinska I Schmitz C Sutherland PA Silbershatz H D'Agostino RB Muller JE Myers RH Levy D Tofler GH Increased platelet aggregability associated with platelet GpIIIa PlA2 polymorphism. The Framingham Offspring Study Arterioscler Thromb Vasc Biol 1999, 19:1142-1147. 10195947
6. Zotz RB Deitenbeck R Rehfeld ISB Maruhn-Debowski B Guenther G Bauer H Winkelmann BR Scharf RE Increased platelet sensitivity related to GPIIIa polymorphism (HPA-b/PLA2) Circulation 1997, 96:664-665.
7. Nurden AT Polymorphism of human platelet membrane glycoprotein: structure and clinical significance Thromb Haemost 1995, 74:345-351. 8578482
8. Vijayan KV Liu Y Dong JF Bray PF Enhanced activation of mitogen-activated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin β3 Biol Chem 2003, 278:3860-3867. 10.1074/jbc.M208680200
9. Wheeler GL Braden GA Bray PF Marciniak SJ Mascelli MA Sane DC Reduced inhibition by abciximab in platelets with the PlA2 polymorphism Am Heart J 2002, 143:76-82. 10.1067/mhj.2002.119763 11773915
10. Böttiger C Kastrati A Koch W Mehilli J Seidl H Schömig K von Beckerath N Schömig A HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction Thromb Haemost 2000, 83:559-562. 10780317
11. Bray PF Cannon CP Goldschmidt-Clermont P Moyé LA Pfeffer MA Sacks FM Braunwald E The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction Am J Cardiol 2001, 88:347-352. 10.1016/ S0002-9149(01)01677-0 11545752
12. Lagercrantz J Bergman M Lundman P Tornvall P Hjemdahl P Hamsten A Eriksson P No evidence that the PLA1/PLA2 polymorphism of the platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction Blood Coagul Fibrinolysis 2003, 14:749-753. 10.1097/00001721-200312000-00010 14614355
13. Benze G Heinrich J Schulte H Rust S Nowak-Göttl U Tataru MC Köhler E Assmann G Junker R Association of the GPIa C807T and GP IIIa PlA1/A2 polymorphisms with premature myocardial infarction in men Eur Heart J 2002, 23:325-330. 10.1053/euhj.2001.2776 11812069
14. Mannucci M Atherosclerosis, Thrombosis, and Vascular Biology Italian Study group No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age Circulation 2003, 107:1117-1122. 10.1161/ 01.CIR.0000051465.94572.D0 12615788
15. French JK Van de Water NS Sutton TM Lund M Gao W McDowell J Liu-Stratton Y Pohorence J Szymanski D Goldschmidt-Clermont P White HD Browett PJ Cooke G Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction Am Heart J 2003, 145:118-124. 10.1067/mhj.2003.29 12514663
16. Bojesen SE Juul K Schnohr P Tybjaerg-Hansen A Nordestgaard BG Copenhagen City Heart Study Platelet glycoprotein IIb/IIIa PlA2/PlA2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men J Am Coll Cardiol 2003, 42:661-667. 10.1016/ S0735-1097(03)00781-2 12932598
17. Kastrati A Schömig A Seyfarth M Koch W Elezi S Böttiger C Mehilli J Schömig K von Beckerath N PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement Circulation 1999, 99:1005-1010. 10051292
18. Kastrati A Koch W Gawaz M Mehilli J Böttiger C Schömig K von Beckerath N Schömig A PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement J Am Coll Cardiol 2000, 36:84-89. 10.1016/S0735-1097(00)00709-9 10898417
19. Walter DH Schächinger V Elsner M Mach S Dimmeler S Auch-Schwelk W Zeiher AM Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the PlA2 allele of the glycoprotein IIIa gene Eur Heart J 2001, 22:587-595. 10.1053/ euhj.2000.2313 11259146
20. Lopes NH Pereira AC Hueb W Soares PR Lanz JR Gersh BJ de Oliveira S Cesar LA Ramires JF Krieger JE Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking Am J Cardiol 2004, 93:1469-1472. 10.1016/ j.amjcard.2004.03.005 15194015
21. Brscic E Bergerone S Gagnor A Colajanni E Matullo G Scaglione L Cassader M Gaschino G Di Leo M Brusca A Pagano GF Piazza A Trevi GP Acute myocardial infarction in young adults: Prognostic role of the angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphism at medium-term follow-up Am Heart J 2000, 139:979-984. 10.1067/mhj.2000.106165 10827377
22. Völzke H Grimm R Robinson DM Wolff B Schwahn C Hertwig S Motz W Rettig R Candidate genetic markers and the risk of restenosis after coronary angioplasty Clin Sci 2004, 106:35-42. 10.1042/CS20030042 12899665
23. Zhu MM Weedon J Clark LT Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction Am J Cardiol 2000, 86:1000-1005. 10.1016/S0002-9149(00)01136-X 11053714
24. Di Castenuovo A De Gaetano G Donatio MB Platelet glycoprotein receptor IIIa polymorphism PlA1/A2 and coronary risk: A meta-analysis Thromb Haemost 2001, 85:626-633. 11341496
25. Burr D Doss H Cooke GE Goldschmidt-Clermont PJ A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart study Stat Med 2003, 22:1741-1760. 10.1002/sim.1375 12720308
26. Miller SA Dykes DD Plesky HF A simple salting-out procedure for extracting DNA from human nucleated cells Nucleic Acid Res 1988, 16:1215. 334765 3344216 10.1093/nar/16.3.1215
27. Laule M Cascorbi I Stangl V Bielecke C Wernecke KD Mrozikiewicz PM Felix SB Roots I Baumann G Stangl K A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: A case-controlled study Lancet 1999, 353:708-712. 10.1016/ S0140-6736(98)07257-2 10073513
28. Shepherd J Cobbe SM Ford I Isles CG Lorimer AR MacFarlane PW McKillop JH Packard CJ Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 1995, 333:1301-1307. 10.1056/NEJM199511163332001 7566020
29. Hjalmarson A Herlitz J Holmberg S Rydén L Swedberg K Vedin A Waagstein F Waldenström A Waldenström J Wedel H Wilhelmsen L Wilhelmsson C The Goteborg metoprolol trial effects on mortality and morbidity in acute myocardial infarction Circulation 1983, 67(6 Pt 2):I26-I32. 6342837
30. Yusuf S Sleight P Pogue J Bosch J Davies R Dagenais G Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 2000, 342:145-153. 10.1056/ NEJM200001203420301 10639539